From USFDA
Strides Shasun has received approval from USFDA for Potassium Citrate Extended Release Tablets USP, 5 mEq, 10 mEq and 15 mEq. The product which is the first approval for an Extended Release tablet for the Company, will be launched immediately.Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)